Legence Corp. (LGN) doubles revenue, books $5.67B backlog and raises 2026 outlook
Rhea-AI Filing Summary
Legence Corp. reported second-quarter 2026 revenue of $1.26 billion, up 110.7% from $598.9 million a year earlier, including strong organic growth after excluding the Bowers acquisition. Non-GAAP Adjusted EBITDA rose 114.1% to $154.6 million with a 12.2% margin.
Despite this growth, Legence recorded a net loss attributable to the company of $27.8 million versus a $5.3 million loss a year ago, reflecting $21.6 million goodwill and $19.5 million long-lived asset impairments, lower gross margins, and much higher stock-based compensation. Backlog and awarded contracts reached a record $5.67 billion, up 104.6% year over year, and the consolidated book-to-bill ratio was 1.2x.
At June 30, 2026, Legence held $292.0 million of cash and $1.03 billion of total debt, implying net leverage of 1.6x based on LTM Adjusted EBITDA, or 1.5x on an adjusted basis including Bowers. The company issued Q3 2026 guidance for revenue of $1.225–$1.275 billion and non-GAAP Adjusted EBITDA of $150–$160 million, and raised full-year 2026 guidance to revenue of $4.7–$4.8 billion and Adjusted EBITDA of $565–$585 million.
Positive
- Revenue more than doubled to $1.26 billion, up 110.7% year over year, with non-GAAP organic revenue growth of 60.0% excluding the Bowers acquisition.
- Non-GAAP Adjusted EBITDA increased 114.1% to $154.6 million, maintaining a 12.2% margin and showing strong earnings expansion alongside revenue growth.
- Backlog and awarded contracts reached $5.67 billion, up 104.6% year over year, supporting future revenue with a consolidated book-to-bill ratio of 1.2x.
- The company reported net leverage of 1.6x LTM Adjusted EBITDA, or 1.5x adjusted net leverage, indicating moderate balance-sheet leverage after significant growth and acquisitions.
- Legence raised full-year 2026 guidance to revenue of $4.7–$4.8 billion and non-GAAP Adjusted EBITDA of $565–$585 million, reflecting management’s higher outlook.
Negative
- Net loss attributable to Legence widened to $27.8 million from $5.3 million a year earlier, despite strong top-line and Adjusted EBITDA growth.
- Results include a $21.6 million goodwill impairment and $19.5 million long-lived asset impairment, signaling write-downs of acquired or existing assets.
- Consolidated gross margin declined from 21.5% to 17.4%, while non-GAAP Adjusted Gross Margin fell from 21.8% to 18.5%, reflecting mix shifts and margin pressure.
- Engineering & Consulting segment non-GAAP Adjusted Gross Margin decreased from 33.2% to 31.1%, and segment gross profit declined 12.4% year over year.
- Stock-based and other non-cash compensation rose sharply to $73.9 million in Q2 2026 from $7.7 million a year earlier, materially impacting GAAP profitability.
Filing Explained
On
8-K Event Classification
Key Figures
Key Terms
Adjusted EBITDA financial
non-GAAP Adjusted Gross Margin financial
backlog and awarded contracts financial
book-to-bill ratio financial
net leverage financial
Tax Receivable Agreement liability remeasurements financial
Earnings Snapshot
Q3 2026 revenue $1.225–$1.275 billion and non-GAAP Adjusted EBITDA $150–$160 million; full-year 2026 revenue $4.7–$4.8 billion and non-GAAP Adjusted EBITDA $565–$585 million.
AI-generated analysis. How Rhea-AI works. Not financial advice.